Axl Receptor Overexpression in Skin Cancer
Author Information
Author(s): Green J, Ikram M, Vyas J, Patel N, Proby C M, Ghali L, Leigh I M, O'toole E A, Storey A
Primary Institution: Cancer Research UK, Skin Tumour Laboratory, London E1 2AT, UK
Hypothesis
Identifying genes that may contribute to squamous cell carcinoma (SCC) progression and serve as potential therapeutic targets.
Conclusion
Axl, a receptor tyrosine kinase, is frequently overexpressed in squamous cell carcinomas compared to normal skin and basal cell carcinomas.
Supporting Evidence
- Axl was upregulated in SCC-derived cells compared to premalignant cells.
- Immunohistochemical analysis showed Axl was overexpressed in 76% of SCCs.
- Statistical analysis indicated significant differences in Axl expression between SCC and normal skin.
Takeaway
This study found that a protein called Axl is found in higher amounts in skin cancer cells than in normal skin, which might help doctors find new ways to treat skin cancer.
Methodology
Gene expression was analyzed using oligonucleotide microarrays, followed by validation with quantitative RT-PCR and immunohistochemistry.
Limitations
The study is based on a small sample size of SCC biopsies.
Participant Demographics
The study involved 17 SCCs from 16 individuals.
Statistical Information
P-Value
0.0001
Confidence Interval
95% CI: 0.3 – 2.3
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website